Fulgent Genetics (FLGT) Competitors $22.51 -0.18 (-0.79%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$22.50 -0.01 (-0.04%) As of 10/10/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FLGT vs. SGRY, CON, GRAL, LFST, CELC, ADUS, PACS, ARDT, NHC, and AVAHShould you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), GRAIL (GRAL), LifeStance Health Group (LFST), Celcuity (CELC), Addus HomeCare (ADUS), PACS Group (PACS), Ardent Health (ARDT), National HealthCare (NHC), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry. Fulgent Genetics vs. Its Competitors Surgery Partners Concentra Group Holdings Parent GRAIL LifeStance Health Group Celcuity Addus HomeCare PACS Group Ardent Health National HealthCare Aveanna Healthcare Surgery Partners (NASDAQ:SGRY) and Fulgent Genetics (NASDAQ:FLGT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Which has more risk & volatility, SGRY or FLGT? Surgery Partners has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Comparatively, Fulgent Genetics has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Is SGRY or FLGT more profitable? Surgery Partners has a net margin of -5.57% compared to Fulgent Genetics' net margin of -16.83%. Surgery Partners' return on equity of 2.51% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Surgery Partners-5.57% 2.51% 1.01% Fulgent Genetics -16.83%-2.26%-2.10% Do analysts prefer SGRY or FLGT? Surgery Partners presently has a consensus target price of $32.00, indicating a potential upside of 62.11%. Fulgent Genetics has a consensus target price of $25.33, indicating a potential upside of 12.54%. Given Surgery Partners' stronger consensus rating and higher possible upside, equities research analysts plainly believe Surgery Partners is more favorable than Fulgent Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surgery Partners 1 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.56Fulgent Genetics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has better earnings & valuation, SGRY or FLGT? Fulgent Genetics has lower revenue, but higher earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Fulgent Genetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgery Partners$3.24B0.78-$168.10M-$1.43-13.80Fulgent Genetics$283.47M2.43-$42.71M-$1.66-13.56 Does the media prefer SGRY or FLGT? In the previous week, Surgery Partners had 6 more articles in the media than Fulgent Genetics. MarketBeat recorded 9 mentions for Surgery Partners and 3 mentions for Fulgent Genetics. Fulgent Genetics' average media sentiment score of 0.83 beat Surgery Partners' score of 0.42 indicating that Fulgent Genetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Fulgent Genetics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of SGRY or FLGT? 48.1% of Fulgent Genetics shares are held by institutional investors. 2.7% of Surgery Partners shares are held by insiders. Comparatively, 33.1% of Fulgent Genetics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummarySurgery Partners beats Fulgent Genetics on 10 of the 16 factors compared between the two stocks. Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGT vs. The Competition Export to ExcelMetricFulgent GeneticsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$689.01M$2.21B$6.04B$10.28BDividend YieldN/AN/A5.68%4.77%P/E Ratio-13.5637.4686.0326.56Price / Sales2.4311.23611.54131.62Price / CashN/A62.0425.7330.17Price / Book0.6112.8112.756.52Net Income-$42.71M-$63.46M$3.31B$276.31M7 Day Performance-1.19%-2.84%0.79%-0.88%1 Month Performance2.88%3.50%6.67%3.48%1 Year Performance13.46%38.28%77.62%30.15% Fulgent Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGTFulgent Genetics3.4033 of 5 stars$22.51-0.8%$25.33+12.5%+13.5%$689.01M$283.47M-13.561,313Analyst ForecastSGRYSurgery Partners3.1366 of 5 stars$20.39-3.6%$31.43+54.1%-35.2%$2.71B$3.24B-14.2615,000News CoverageAnalyst ForecastCONConcentra Group Holdings Parent3.042 of 5 stars$20.65-0.5%$27.75+34.4%+1.0%$2.66B$1.90B17.3511,250Analyst ForecastGRALGRAIL1.125 of 5 stars$61.70-5.9%$56.67-8.2%+356.4%$2.36B$125.60M-4.711,360Analyst ForecastInsider TradeLFSTLifeStance Health Group3.3764 of 5 stars$5.61+1.8%$8.50+51.5%-27.4%$2.14B$1.25B-112.2010,218News CoverageAnalyst UpgradeCELCCelcuity2.7278 of 5 stars$47.81-5.3%$56.50+18.2%+203.9%$2.14BN/A-13.8640Analyst ForecastADUSAddus HomeCare4.9608 of 5 stars$112.70-1.9%$138.89+23.2%-13.6%$2.12B$1.27B24.8849,703Positive NewsAnalyst ForecastPACSPACS Group2.6271 of 5 stars$13.85+1.2%$31.00+123.8%-67.5%$2.09B$3.11B0.0032,433ARDTArdent Health3.8063 of 5 stars$14.45+3.1%$19.33+33.8%-25.8%$2.01B$6.20B7.9824,900News CoveragePositive NewsAnalyst ForecastNHCNational HealthCareN/A$118.44-2.4%N/A-2.5%$1.84B$1.46B14.8412,400News CoverageAVAHAveanna Healthcare1.4324 of 5 stars$8.51-1.4%$7.92-7.0%+74.0%$1.80B$2.02B106.3833,500Analyst Forecast Related Companies and Tools Related Companies SGRY Competitors CON Competitors GRAL Competitors LFST Competitors CELC Competitors ADUS Competitors PACS Competitors ARDT Competitors NHC Competitors AVAH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGT) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
